1st Quarter - Report

SUMMIT PUBLIC AFFAIRS for VANDA PHARMACEUTICALS INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Administration of the 21st Century Cares Act (Pub. L. No. 114-255). H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. H.R. 6201, Families First Coronavirus Response Act. H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. COVID-19 Clinical Trials. FY2021 Appropriations - outreach regarding appropriations language requests.

LobbyistCovered position, as disclosed
CICELY SIMPSON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 6074 (116th), H.R. 6201 (116th), H.R. 748 (116th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.